RI Innovator Series: How to fund & bring a novel diagnostic to market

Share on Social Media

Novel clinical diagnostic can pinpoint disease, improve treatment decisions, even save lives. Yet developers face steep challenges and the entrepreneurial journey is filled with ups, downs and, sometimes, catastrophes. How do you not only stay the course, but succeed?

The experts from Ciencia, Inc. will share their experiences and discuss how to fund and bring a novel diagnostic to market, how to overcome challenges, and how to form strategic partnerships with corporate clients. Plus:

  • The importance of SBIR grants – and winning them
  • What and why clinical diagnostics matter
  • The effect on healthcare costs
  • How to position your innovation for the marketplace

Who should attend
Anyone involved in bringing a diagnostic to market, including researchers, entrepreneurs, clinicians, students, scientists, and investors.


Carol Malysz, Executive Director, RI Bio


Arturo Pilar, President
Arturo has been with the company since its founding and now oversees all development efforts for Centinela’s grating-coupled fluorescent plasmonics (GC-FP) technology. He has been instrumental in raising nearly $10M in government grant and private funding for the project to bring this technology into research laboratories. Under his leadership, Ciencia has developed several successful technologies, and he is actively working to bring them to market.

William Page, Senior Researcher
William worked on the development of the GC-FP technology that underlies the Centinela platform and is leading a project to simplify and streamline the instrumentation to bring GC-FP out of research labs and unlock its full clinical potential. He is the primary author of ten awarded SBIR/STTR grants and the author of several of Ciencia’s patents. He is also a practicing Internal Medicine physician at the Miriam Hospital and understands the limitations of established diagnostics.  

About Ciencia
Ciencia uses cutting-edge innovation in optical sciences to solve real-world problems, primarily through contract research and development. The company has successfully designed and prototyped a variety of instruments for government and industrial clients since 1992. Much of their work has been done in response to Small Business Innovative Research (SBIR) solicitations and their team of experienced scientist and engineers have been awarded more than 50 Phase I and 20 Phase II SBIR contracts. They have a loyal and increasing customer base who recognize GC-FP as a cost-effective way to get important answers to their research questions, including collaborators at SUNY Polytechnic Institute, the Wadsworth Institute, Brown University, and the University of Connecticut.



Upcoming Events